In the SURMOUNT-1 trial, participants without diabetes achieved an average body weight reduction of up to about 22.5% after 72 weeks at the highest dose, one of the largest reductions reported for a medication in obesity research
These individuals have typically found their minimum effective maintenance dose and view the medication as routine health management
The lack of robust clinical trial data on this combination means that potential drug interactions, additive side effects, and long-term safety outcomes remain inadequately characterized
It works locally at the cellular level to repair tissue, reduce inflammation, and reset gene expression
Total Med Solutions offers prescription weight loss programs including Semaglutide and Tirzepatide, designed for safe and effective results
How long do GLP-1 injections take to show weight loss results